Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum

Deep Infections Caused by Scedosporium prolificans: A Report on 16 Cases in Spain and a Review of the Literature

1997 • 209 citations

In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens

1997 • 187 citations

Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia

1997 • 169 citations

Ecology and physiology of the emerging opportunistic fungi Pseudallescheria boydii and Scedosporium prolificans

1994 • 112 citations

Comparison of voriconazole (UK-109,496) and itraconazole in prevention and treatment of Aspergillus fumigatus endocarditis in guinea pigs

1997 • 111 citations

Itraconazole: pharmacology, clinical experience and future development

1996 • 94 citations

Improved medium for fluconazole susceptibility testing of Candida albicans

1994 • 70 citations